MicroRNAs are short RNA strands, of which more than 2,300 have been identified in humans. Their abnormal expression contributes to the development of many diseases, such as…
Johanna Ivaska has been selected to join Academia Europaea as an invited member
Academia Europaea is a European, non-governmental association acting as an Academy which covers all disciplines and invites distinguished scientists to become members based on peer review. – It is a…
Researchers Identify Gene Expression Signature That Predicts Progression of Type 1 Diabetes
Researchers from Turku Bioscience Centre and InFLAMES Flagship at the University of Turku in Finland, have identified a gene expression signature that can predict the progression of type 1 diabetes.
SAVE THE DATE: BioCity PhD Mini-Symposium is coming!
A team of Doctoral Researchers are delighted to announce the BioCity PhD Mini-Symposium planned on the afternoon before the main symposium, i.e., on Wednesday 23rd August, 2023. This will be an ideal platform…
Mikael Knip of the University of Helsinki is conferred as a Turku University Honorary Doctor in medicine
Mikael Knip of the University of Helsinki is conferred as a Turku University honorary doctor in medicine for his merits in the research of type 1 diabetes. Knip is one…
Turku Bioscience funding news May 2023
We are delighted to share the following funding news with everyone. Warmest congratulations to those who got funded. BioCity Turku Collaborative Research Funding Call Results All funded…
The EURAS project received over 8 million euros funding from the Health Cluster of the Horizon Europe Research and Innovation Programme
The EURAS consortium received Horizon funding to develop new treatments for rare neurodevelopmental disorders of the Ras pathway.
A position on the EURAS project is now open for applications (deadline extended until 1 August 2023)
Our lab has now opened a position to join us on the EURAS consortium project. The deadline for applications is now extended until 1 August 2023. The…
The EURAS project has been awarded ~8 million euros funding from the Health Cluster of the Horizon Europe Research and Innovation Programme
Rare neurodevelopmental disorders of the Ras pathway continue to evade effective treatment. The EURAS consortium has been awarded ~8 million euros from the Health Cluster of the Horizon Europe…
DDCB symposium on May 4th 2023
How could your research benefit from the chemical biology and drug discovery tools and infrastructure available in Finland? Find out on 4th May 2023 at the symposium held by the…